DaVita Inc. ($DVA) Stock Forecast: Down 10.5% Today

What is DaVita Inc.?

DaVita Inc. (DVA) observed a significant bearish movement in the stock market today.

Why is DaVita Inc. going down?

DVA stock is down 10.5% on Feb 14, 2025 17:43

• Despite DaVita's strong performance in Q4 and improved margins, the stock faced a bearish trend, possibly hinting at elevated market expectations.
• The company's cautious future outlook, along with escalating care expenses, contributed to the unsatisfactory guidance that impacted the stock negatively.
• The decision of a major shareholder to offload some DaVita shares, as part of a predetermined arrangement, added to the selling pressure on the stock.
• Factors like reduced holdings by the major shareholder, weaker projections for 2025, and the market's response to the financial results and revenue forecasts likely instigated the notable decline in DaVita's stock value today.

DVA Price Chart

DVA Technical Analysis

DVA News

DVA Stock Down in Pre-Market Despite Q4 Earnings Beat, Margins Expand

Robust segmental revenues drive DaVita's fourth-quarter 2024 performance despite a per-day decrease of the total U.S. dialysis treatments on a sequential basis.

https://www.zacks.com/stock/news/2416324/dva-stock-down-in-pre-market-despite-q4-earnings-beat-margins-expand

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

DaVita shares tumbled after issuing a weak outlook amid rising care costs, while big investor Berkshire offloaded some shares in a pre-planned agreement.

https://www.cnbc.com/2025/02/14/warren-buffetts-berkshire-hathaway-sells-some-davita-shares-fall-on-disappointing-guidance.html

DaVita Plunges Over 10% In Friday Pre-Market. What's Wrong? - DaVita ( NYSE:DVA )

The shares of DaVita Inc.DVA plunged 10.2% in pre-market hours trading on Friday after Berkshire Hathaway trimmed its stake in the company. The dialysis provider also issued a weak outlook for 2025 as it announced its results after the market closed on Thursday.

https://www.benzinga.com/general/health-care/25/02/43725529/davita-plunges-over-10-in-friday-pre-market-after-warren-buffett-cuts-stake-in-one-of-berkshi

Warren Buffett's Berkshire Hathaway Sells Nearly $36 Million Worth Of Dialysis Giant DaVita's Shares Amid Q4 Earnings Beat - SPDR S&P 500 ( ARCA:SPY ) , DaVita ( NYSE:DVA )

Buffett's Berkshire reduced its stake to 45% in DVA abiding by its earlier share repurchase agreement. According to Reuters, Berkshire has owned DaVita since the fourth quarter of 2011. Get two weeks of free access to pro-level trading tools, including news alerts, scanners, and real-time market ...

https://www.benzinga.com/general/market-summary/25/02/43721022/warren-buffetts-berkshire-hathaway-sells-nearly-36-million-worth-of-dialysis-giant-davitas

DaVita HealthCare ( DVA ) Beats Q4 Earnings and Revenue Estimates

DaVita HealthCare (DVA) delivered earnings and revenue surprises of 1.36% and 1.22%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2415779/davita-healthcare-dva-beats-q4-earnings-and-revenue-estimates

Trending Today

Sabre Corporation ($SABR) Stock Forecast: Up 13.6% Today

Hasbro Inc. ($HAS) Stock Forecast: Up 13.9% Today

Unity Software ($U) Stock Forecast: Up 27.7% Today

Walmart Inc. ($WMT) Stock Forecast: Down 6.2% Today

Arweave ($AR) Crypto Forecast: Up 11.2% Today

Hims & Hers Health Inc. ($HIMS) Stock Forecast: Down 8.3% Today

Palantir Technologies Inc ($PLTR) Stock Forecast: Down 18.2% Today

Alibaba Group Holding Limited ($BABA) Stock Forecast: Up 6.6% Today

Stox ($STX) Crypto Forecast: Up 5.1% Today

Sui ($SUI) Crypto Forecast: Up 6.2% Today

DaVita Inc. Price History

30.07.2024 - DVA Stock was down 2.7%

• The CFO and CEO of DaVita Inc. have recently sold a significant amount of company stock, totaling over $16 million, which could indicate a lack of confidence in the company's future performance.
• Insider selling can raise investor concerns about the company's prospects, leading to a negative sentiment in the market.
• The insider selling news may have contributed to a significant decline in DaVita's stock price today.
• Investors may view these insider sales as a warning sign and choose to sell their DaVita positions, causing the stock price to drop further.

30.09.2024 - DVA Stock was down 6.6%

• DaVita HealthCare (DVA) reported Q3 earnings that missed estimates by -6.16%, which could have contributed to the bearish movement.
• Despite an expected improvement in Revenue Per Treatment (RPT), the stock still experienced a negative change of -0.23%, possibly due to the earnings miss.
• Investors may be cautious about the future outlook of DVA, considering the earnings surprise and the slight decline in stock price.

30.09.2024 - DVA Stock was down 11.8%

• The bearish trend in DVA's stock can be linked to the company's Q3 earnings falling short of expectations.
• Despite strong Dialysis patient service revenues, the overall performance did not meet projections, leading to a negative market response.
• Investors' reaction to the -6.16% earnings surprise and 1.29% revenue miss likely contributed to the stock price drop.
• Market movements indicate investor caution regarding DVA's future performance and their interest in how the company addresses the missed estimates in the upcoming quarters.

12.08.2024 - DVA Stock was up 5.2%

• DaVita HealthCare (DVA) saw a bullish movement as the stock gained +0.29%.
• The company's focus on providing essential kidney care services in the US likely contributed to investor optimism.
• DaVita's intriguing valuation and its importance in societal health could have attracted investors looking for stable growth opportunities.
• The bullish trend in the stock reflects confidence in DaVita's business model and its position in the healthcare industry.

19.06.2024 - DVA Stock was down 5.1%

• DaVita's stock has been performing well year-to-date, gaining 29.8%, driven by strong fundamentals.
• The bearish movement today could be attributed to concerns over the company's reliance on commercial payers, which might have spooked investors.
• Despite the recent downturn, the long-term prospects for DaVita could still be positive given its solid fundamentals and market position.

14.00.2025 - DVA Stock was up 5.3%

• DVA displayed a robust bullish trend despite the market drop.
• This positive momentum may stem from solid financial performance or favorable developments in the healthcare sector.
• Investors seem to trust DaVita's capacity to manage market changes effectively and provide steady outcomes.
• The upward movement in DVA might reflect investor confidence in the company's future outlook and expansion opportunities in the healthcare field.

14.01.2025 - DVA Stock was down 13.1%

• DaVita's shares plunged over 10% in pre-market trading after Berkshire Hathaway trimmed its stake in the company, leading to investor concerns and selling pressure.
• The weak outlook for 2025 issued by DaVita, citing rising care costs and supply challenges, further contributed to the bearish sentiment surrounding the stock.
• Despite beating Q4 earnings and revenue estimates, the market reaction was overshadowed by Berkshire's sell-off and the cautious guidance provided by DaVita for the upcoming year.
• The combination of Berkshire's share reduction, disappointing future outlook, and ongoing industry challenges likely fueled the significant bearish movement in DaVita's stock price today.

24.04.2024 - DVA Stock was up 5.1%

• DaVita's shares surged by 34.5% year to date, outperforming the industry and the S&P 500 Composite.
• The company's strong momentum is driven by healthy fundamentals and growth opportunities in its Dialysis and related lab services.
• However, concerns about its dependence on commercial payers could be a potential risk factor for the stock in the future.
• The collaboration between Centene and Cityblock to enhance value-based care in Central Florida's Medicaid members could also have positively influenced investor sentiment towards DaVita, as it operates in a similar healthcare sector.

15.06.2024 - DVA Stock was down 2.1%

• The unveiling of a novel kidney disease training curriculum by Dialysis Patient Citizens could have raised concerns among investors regarding potential future competition or industry changes that might impact DaVita HealthCare's market standing.
• Despite outperforming the S&P 500 in the latest trading session, the market's overall bearish trend, exemplified by the Dow's decline, potentially prompted investors to divest from DaVita HealthCare shares, contributing to the stock's downward trajectory.
• Investors might have opted to capitalize on the slight stock price increase, particularly amidst a volatile market environment characterized by uncertainties and rapid market fluctuations.

26.06.2024 - DVA Stock was down 4.0%

• DVA stock experienced a notable bearish movement following the company agreeing to pay $34.5 million for alleged kickbacks. This development could have triggered investor concerns, resulting in a sell-off.
• Amid the general market decline, DVA's legal issues and potential financial consequences outweighed any positive market shifts, leading to a significant stock drop.
• Investor apprehensions regarding how these legal challenges could affect DVA's reputation and financial performance contributed to a bearish outlook and a decline in the stock price.

07.07.2024 - DVA Stock was down 5.0%

• Despite exceeding Q2 earnings estimates and raising its income guidance for 2024, DaVita Inc. witnessed a decline in its stock price.
• This decrease could be linked to investors selling shares to capture profits or in response to expectations of even higher earnings and guidance.
• Potential concerns raised during the earnings call may have influenced investor confidence despite the positive financial results.
• The stock movement might also be influenced by general market conditions or specific challenges affecting the healthcare sector.

14.01.2025 - DVA Stock was down 10.5%

• Despite DaVita's strong performance in Q4 and improved margins, the stock faced a bearish trend, possibly hinting at elevated market expectations.
• The company's cautious future outlook, along with escalating care expenses, contributed to the unsatisfactory guidance that impacted the stock negatively.
• The decision of a major shareholder to offload some DaVita shares, as part of a predetermined arrangement, added to the selling pressure on the stock.
• Factors like reduced holdings by the major shareholder, weaker projections for 2025, and the market's response to the financial results and revenue forecasts likely instigated the notable decline in DaVita's stock value today.